Get the Stockscreener App
2.46
8.37%
0.19
After Hours:
2.47
0.01
+0.41%
Nuvation Bio Inc stock is traded at $2.46, with a volume of 5.89M.
It is up +8.37% in the last 24 hours and up +37.43% over the past month.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
See More
Previous Close:
$2.27
Open:
$2.31
24h Volume:
5.89M
Relative Volume:
2.21
Market Cap:
$723.49M
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-7.0286
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
+15.49%
1M Performance:
+37.43%
6M Performance:
+6.96%
1Y Performance:
-24.77%
1-Day Range:
$2.31
$2.54
1-Week Range:
$2.10
$2.54
52-Week Range:
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.46 | 723.49M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-25 | Initiated | Citizens JMP | Mkt Outperform |
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
Nuvation Bio Inc (NUVB) Stock: A Year of Stock Market Dynamics - investchronicle.com
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
LPL Financial LLC Grows Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at The Citizens Life Sciences Conference - BioSpace
Nuvation Bio Inc [NUVB] Records 50-Day SMA of $1.98 - knoxdaily.com
Nuvation Bio Inc (NUVB) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Nuvation Bio Inc (NUVB)’s stock price range in the last year - uspostnews.com
Renaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Legal & General Group Plc Buys 62,877 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc [NUVB] Investment Guide: What You Need to Know - knoxdaily.com
An Overview of Nuvation Bio Inc (NYSE: NUVB)’s Stock Performance and Outlook - Marketing Sentinel
Russell Investments Group Ltd. Buys 15,791 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP Securities - Defense World
Nuvation Bio (NYSE:NUVB) Earns Mkt Outperform Rating from Analysts at Citizens Jmp - Defense World
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.83 - Defense World
Nuvation Bio Inc [NUVB] Records 200-Day SMA of $2.57 - knoxdaily.com
Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com
Investor’s Delight: Nuvation Bio Inc (NUVB) Closes Strong at 2.06, Up 4.04 - DWinneX
Citizens JMP sets Nuvation Bio stock at $6 target, Market Outperform - Investing.com Canada
Nuvation Bio (NUVB) Receives Outperform Rating with Promising Ca - GuruFocus
Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025 - BioSpace
Nuvation Bio Inc (NUVB): What Makes The Stock Good? - Marketing Sentinel
Geode Capital Management LLC Raises Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Federated Hermes Inc. Sells 349,503 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Cuts Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
American Century Companies Inc. Raises Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 43,500 Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio CEO David Hung purchases $820,220 in company stock - Investing.com Australia
Nuvation Bio CEO David Hung purchases $820,220 in company stock By Investing.com - Investing.com South Africa
10 Stocks Under $10 that Will Triple - Insider Monkey
Institutional owners may take dramatic actions as Nuvation Bio Inc.'s (NYSE:NUVB) recent 8.8% drop adds to one-year losses - simplywall.st
Teacher Retirement System of Texas Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference - BioSpace
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio Inc (NYSE: NUVB) – An Analysis Is What You Need - stocksregister.com
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week LowHere's Why - MarketBeat
Quantbot Technologies LP Decreases Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com
Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register
Nuvation Bio (NYSE:NUVB) Receives Outperform Rating from Wedbush - The AM Reporter
Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):